Development of Highly Efficient Lysosome‐Targeting Peptide Ligands for the Internalization of Extracellular Proteins
ChemBioChem · 12.11.2026 · 27 (21)
DOI: 10.1002/cbic.70587 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, online erschienen am 28.10.2026. Verfasst von Yuan Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Lachman Institute of Pharmaceutical Development, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Lysosomes, Peptides, Receptor, IGF Type 2. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Lysosome‐targeting chimeras (LYTACs) induce the internalization of extracellular and membrane‐associated proteins by routing them to lysosomes via endogenous receptors, such as the insulin‐like growth factor‐2 receptor (IGF2R), also known as cation‐independent mannose‐6‐phosphate receptor. While current IGF2R ligands are effective, expanding the LYTAC toolkit with structurally simple and synthetically accessible ligands remains a practical necessity. Here, we first validated that previously reported dimeric and monomeric peptides induce robust internalization, establishing them as effective IGF2R‐targeting LYTAC ligands. To further optimize the peptide architecture, we performed systematic mutational scanning on its monomeric sequence to simplify the peptide architecture. We identified the L4 variant, which features a single leucine substitution at the fourth position. This optimized monomer induces greater internalization efficiency than the previously reported wild‐type monomeric peptide ligand. To demonstrate its utility, we conjugated the L4 recruiter to a specific PCSK9 binder. The resulting bifunctional molecule successfully induced the dose‐ and time‐dependent internalization of PCSK9. Collectively, these findings establish several peptide variants as practical and highly effective building blocks for the development of extracellular protein internalization platforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Lachman Institute of Pharmaceutical Development, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Chemical Biology, Novo Nordisk US R&D, Lexington, Massachusetts, USA.
ORCID-Profile: Xuankun Chen, Deqin Cai, Hua Tang, Nick Cox, Alexander N Zaykov, Weiping Tang
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Zhao, Y., Liao, Y., Chen, X., Cai, D., Gonzalez, R. S., Tang, H., Brunel, F. M., Cox, N., Stock, J., Fu, G., Zaykov, A. N., & Tang, W. (2026). Development of Highly Efficient Lysosome‐Targeting Peptide Ligands for the Internalization of Extracellular Proteins. ChemBioChem, 27(21). https://doi.org/10.1002/cbic.70587
Vancouver
Zhao Y, Liao Y, Chen X, Cai D, Gonzalez RS, Tang H, et al. Development of Highly Efficient Lysosome‐Targeting Peptide Ligands for the Internalization of Extracellular Proteins. ChemBioChem. 2026;27(21). doi:10.1002/cbic.70587
BibTeX
@article{Zhao2026,
author = {Zhao, Yuan and Liao, Yaxian and Chen, Xuankun and Cai, Deqin and Gonzalez, Regina Stasser de and Tang, Hua and Brunel, Florence M and Cox, Nick and Stock, Joseph and Fu, Guangsen and Zaykov, Alexander N and Tang, Weiping},
title = {Development of Highly Efficient Lysosome‐Targeting Peptide Ligands for the Internalization of Extracellular Proteins},
journal = {ChemBioChem},
year = {2026},
volume = {27},
number = {21},
doi = {10.1002/cbic.70587}
}
EUVIMED